STOCK TITAN

Nu-Med Plus Stock Price, News & Analysis

NUMD OTC Link

Company Description

Nu-Med Plus (OTC Link: NUMD) is a publicly traded medical devices company in the Healthcare sector. The company has a market capitalization of $930.7K.

NUMD stock has declined 86.5% over the past year. Shares last traded at $0.0119.

On a trailing twelve-month basis, Nu-Med Plus reported net income of -$68K and diluted earnings per share of $0.00.

This page provides a comprehensive overview of NUMD stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

$0.0119
+7.21%
+0.00
Last updated: April 6, 2026 at 14:29
-86.49%
Performance 1 year
$930.7K

Nu-Med Plus (NUMD) stock last traded at $0.0119, up 7.21% from the previous close. Over the past 12 months, the stock has lost 86.5%. At a market capitalization of $930.7K, NUMD is classified as a micro-cap stock with approximately 83.5M shares outstanding.

Latest News

No recent news available for NUMD.

SEC Filings

Nu-Med Plus has filed 2 recent SEC filings, including 1 Form NT 10-K, 1 Form 10-Q. The most recent filing was submitted on March 31, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all NUMD SEC filings →

Financial Highlights

operating income reached -$63K, and net income was -$68K. Diluted earnings per share stood at $0.00. The company generated -$4K in operating cash flow. With a current ratio of 0.04, short-term liquidity bears monitoring.

-$68K
Net Income (TTM)
-$4K
Operating Cash Flow
Revenue (TTM)

Upcoming Events

Short Interest History

Last 12 Months

Short interest in Nu-Med Plus (NUMD) currently stands at 35.7 thousand shares, representing 0.1% of the float. Over the past 12 months, short interest has increased by 66.4%. This relatively low short interest suggests limited bearish sentiment.

Days to Cover History

Last 12 Months

Days to cover for Nu-Med Plus (NUMD) currently stands at 1.4 days, down 99.8% from the previous period. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed. The days to cover has increased 43% over the past year, indicating improving liquidity conditions. The ratio has shown significant volatility over the period, ranging from 1.0 to 892.2 days.

NUMD Company Profile & Sector Positioning

Nu-Med Plus (NUMD) operates in the Medical Devices industry within the broader Healthcare sector and is listed on the OTC Link.

Frequently Asked Questions

What is the current stock price of Nu-Med Plus (NUMD)?

The current stock price of Nu-Med Plus (NUMD) is $0.0119 as of April 6, 2026.

What is the market cap of Nu-Med Plus (NUMD)?

The market cap of Nu-Med Plus (NUMD) is approximately 930.7K. Learn more about what market capitalization means .

What is the net income of Nu-Med Plus (NUMD)?

The trailing twelve months (TTM) net income of Nu-Med Plus (NUMD) is -$68K.

What is the earnings per share (EPS) of Nu-Med Plus (NUMD)?

The diluted earnings per share (EPS) of Nu-Med Plus (NUMD) is $0.00 on a trailing twelve months (TTM) basis. Learn more about EPS .

What is the operating cash flow of Nu-Med Plus (NUMD)?

The operating cash flow of Nu-Med Plus (NUMD) is -$4K. Learn about cash flow.

What is the current ratio of Nu-Med Plus (NUMD)?

The current ratio of Nu-Med Plus (NUMD) is 0.04, indicating the company's ability to pay short-term obligations. Learn about liquidity ratios.

What is the operating income of Nu-Med Plus (NUMD)?

The operating income of Nu-Med Plus (NUMD) is -$63K. Learn about operating income.